Sagimet Biosciences Inc. (SGMT): Shareholders' Equity
$111.38M
As of 2025-12-31
$256.15M
As of 2026-06-30
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $111.38M | -28.5% | 2026-03-11, Balance as of period end |
| 2024-12-31 | $155.81M | +71.1% | 2026-03-11, Balance as of period end |
| 2023-12-31 | $91.06M | n/m | 2025-03-12, Balance as of period end |
| 2022-12-31 | -$186.95M | n/a | 2024-03-25, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Sagimet Biosciences Inc. (SGMT) | 2025-12-31 | $111.38M | -28.5% |
| Avalo Therapeutics, Inc. (AVTX) | 2025-12-31 | $83.05M | -37.6% |
| PMV Pharmaceuticals, Inc. (PMVP) | 2025-12-31 | $104.71M | -40.5% |
| Aardvark Therapeutics, Inc. (AARD) | 2025-12-31 | $106.63M | n/m |
| Camp4 Therapeutics Corp (CAMP) | 2025-12-31 | $47.70M | -24.5% |
| Filana Therapeutics, Inc. (FLNA) | 2025-12-31 | $74.40M | -48.9% |
| Rafael Holdings, Inc. (RFL) | 2025-07-31 | $98.37M | +14.0% |
| Milestone Pharmaceuticals Inc. (MIST) | 2025-12-31 | $41.77M | +217.7% |
| Korro Bio, Inc. (KRRO) | 2025-12-31 | $51.44M | -67.9% |
Compare SGMT, AVTX, PMVP, AARD side by side · Screen every company in Pharmaceutical Preparations ↗